Welgene Biotech Co.,Ltd. (6661.TWO)

TWD 23.6

(0.85%)

Total Assets Summary of Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.'s latest annual total assets in 2023 was 548.16 Million TWD , up 25.81% from previous year.
Welgene Biotech Co.,Ltd.'s latest quarterly total assets in 2024 Q2 was 525.9 Million TWD , up 1.64% from previous quarter.
Welgene Biotech Co.,Ltd. reported annual total assets of 435.71 Million TWD in 2022, up 2.63% from previous year.
Welgene Biotech Co.,Ltd. reported annual total assets of 424.53 Million TWD in 2021, up 17.83% from previous year.
Welgene Biotech Co.,Ltd. reported quarterly total assets of 525.9 Million TWD for 2024 Q2, up 1.64% from previous quarter.
Welgene Biotech Co.,Ltd. reported quarterly total assets of 548.16 Million TWD for 2023 FY, up 25.81% from previous quarter.

Annual Total Assets Chart of Welgene Biotech Co.,Ltd. (2023 - 2014)

Historical Annual Total Assets of Welgene Biotech Co.,Ltd. (2023 - 2014)

Year	Total Assets	Total Assets Growth
2023	548.16 Million TWD	25.81%
2022	435.71 Million TWD	2.63%
2021	424.53 Million TWD	17.83%
2020	360.28 Million TWD	-14.67%
2019	422.25 Million TWD	16.53%
2018	362.33 Million TWD	16.13%
2017	311.99 Million TWD	13.03%
2016	276.02 Million TWD	-1.94%
2015	281.5 Million TWD	26.51%
2014	222.5 Million TWD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	517.44 Million TWD	-5.6%
2024 Q2	525.9 Million TWD	1.64%
2023 FY	548.16 Million TWD	25.81%
2023 Q3	506.8 Million TWD	-4.45%
2023 Q4	548.16 Million TWD	8.16%
2023 Q1	436.25 Million TWD	0.12%
2023 Q2	530.42 Million TWD	21.59%
2022 Q3	387.75 Million TWD	4.65%
2022 Q2	370.52 Million TWD	-6.78%
2022 Q1	397.46 Million TWD	-6.38%
2022 FY	435.71 Million TWD	2.63%
2022 Q4	435.71 Million TWD	12.37%
2021 Q1	406.39 Million TWD	12.8%
2021 Q3	368.01 Million TWD	-5.71%
2021 Q4	424.53 Million TWD	15.36%
2021 FY	424.53 Million TWD	17.83%
2021 Q2	390.28 Million TWD	-3.96%
2020 Q4	360.28 Million TWD	0.19%
2020 FY	360.28 Million TWD	-14.67%
2020 Q3	359.58 Million TWD	-6.68%
2020 Q2	385.32 Million TWD	0.0%
2020 Q1	- TWD	-100.0%
2019 Q2	367.23 Million TWD	0.0%
2019 Q1	367.23 Million TWD	1.35%
2019 FY	422.25 Million TWD	16.53%
2019 Q4	422.25 Million TWD	0.0%
2018 Q4	362.33 Million TWD	0.0%
2018 FY	362.33 Million TWD	16.13%
2018 Q1	298.89 Million TWD	-4.2%
2018 Q2	298.89 Million TWD	0.0%
2018 Q3	362.33 Million TWD	21.22%
2017 Q2	277.78 Million TWD	0.0%
2017 Q1	277.78 Million TWD	0.64%
2017 Q4	311.99 Million TWD	0.0%
2017 Q3	311.99 Million TWD	12.32%
2017 FY	311.99 Million TWD	13.03%
2016 FY	276.02 Million TWD	-1.94%
2016 Q4	276.02 Million TWD	0.0%
2016 Q3	276.02 Million TWD	0.0%
2015 FY	281.5 Million TWD	26.51%
2014 FY	222.5 Million TWD	0.0%

Peer Total Assets Comparison of Welgene Biotech Co.,Ltd.

Name	Total Assets	Total Assets Difference
BIONET Corp.	2.34 Billion TWD	76.66%
DIVA Laboratories, Ltd.	1.24 Billion TWD	55.926%
Genetics Generation Advancement Corp.	595.05 Million TWD	7.88%
Puriblood Medical Co., Ltd.	265.51 Million TWD	-106.455%
TFBS Bioscience Inc.	1.44 Billion TWD	62.144%